Literature DB >> 24064268

Overcoming poor oral bioavailability using nanoparticle formulations - opportunities and limitations.

.   

Abstract

Year:  2012        PMID： 24064268     DOI： 10.1016/j.ddtec.2011.12.001

Source DB:  PubMed          Journal:  Drug Discov Today Technol        ISSN： 1740-6749


× No keyword cloud information.
  35 in total

Review 1.  A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.

Authors:  Abhijit A Date; Christopher J Destache
Journal:  Biomaterials       Date:  2013-05-28       Impact factor: 12.479

Review 2.  Potential Strategies to Reduce Blood Pressure in Treatment-Resistant Hypertension Using Food and Drug Administration-Approved Nanodrug Delivery Platforms.

Authors:  Ibra S Fancher; Israel Rubinstein; Irena Levitan
Journal:  Hypertension       Date:  2019-02       Impact factor: 10.190

Review 3.  Scientific and Regulatory Considerations for Generic Complex Drug Products Containing Nanomaterials.

Authors:  Nan Zheng; Dajun D Sun; Peng Zou; Wenlei Jiang
Journal:  AAPS J       Date:  2017-01-23       Impact factor: 4.009

4.  Development and physicochemical characterization of sirolimus solid dispersions prepared by solvent evaporation method.

Authors:  Shahram Emami; Hadi Valizadeh; Ziba Islambulchilar; Parvin Zakeri-Milani
Journal:  Adv Pharm Bull       Date:  2014-08-10

5.  Loratadine self-microemulsifying drug delivery systems (SMEDDS) in combination with sulforaphane for the synergistic chemoprevention of pancreatic cancer.

Authors:  Preshita Desai; Arvind Thakkar; David Ann; Jeffrey Wang; Sunil Prabhu
Journal:  Drug Deliv Transl Res       Date:  2019-06       Impact factor: 4.617

Review 6.  Computational nanomedicine: modeling of nanoparticle-mediated hyperthermal cancer therapy.

Authors:  Chanchala D Kaddi; John H Phan; May D Wang
Journal:  Nanomedicine (Lond)       Date:  2013-08       Impact factor: 5.307

7.  Efficacy and Pharmacokinetic Considerations of Loratadine Nanoformulations and its Combinations for Pancreatic Cancer Chemoprevention.

Authors:  Preshita Desai; Kevin Zhijun Wang; David Ann; Jeffrey Wang; Sunil Prabhu
Journal:  Pharm Res       Date:  2020-01-02       Impact factor: 4.200

Review 8.  "Fusion and binding inhibition" key target for HIV-1 treatment and pre-exposure prophylaxis: targets, drug delivery and nanotechnology approaches.

Authors:  Tanushree Malik; Gaurav Chauhan; Goutam Rath; R S R Murthy; Amit K Goyal
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 9.  Nanocarriers as treatment modalities for hypertension.

Authors:  Tausif Alam; Saba Khan; Bharti Gaba; Md Faheem Haider; Sanjula Baboota; Javed Ali
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 10.  Achievements in Thermosensitive Gelling Systems for Rectal Administration.

Authors:  Maria Bialik; Marzena Kuras; Marcin Sobczak; Ewa Oledzka
Journal:  Int J Mol Sci       Date:  2021-05-23       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.